Structure of a synthetic fragment of the lipopolysaccharide (LPS) binding protein when bound to LPS and design of a peptidic LPS inhibitor

Journal of Medicinal Chemistry

Volumn 48, Issue 24, 2005, Pages 7911-7914

  Pristovšek, Primož ^a   Simčic, Saša ^b   Wraber, Branka ^b   Urleb, Uroš ^c  

^a NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c Lek dd   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLVALYLGLUTAMYLGLYCYLARGINYLTRYPTOPHYLLYSYLVALYLARGINYLALANYLSERYLPHEN YLALANYLPHENYLALANYLLYSINE; LBP 14; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOPOLYSACCHARIDE BINDING PROTEIN INHIBITOR; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; CONTROLLED STUDY; DRUG BINDING; DRUG DESIGN; DRUG STRUCTURE; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT;

ACUTE-PHASE PROTEINS; ANTI-BACTERIAL AGENTS; CARRIER PROTEINS; CELLS, CULTURED; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE GLYCOPROTEINS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PEPTIDE FRAGMENTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 28144454203     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050762a     Document Type: Article

References (26)

1. Van Amersfoort, E. S.; Van Berkel, T. J.; Kuiper, J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin. Microbiol. Rev. 2003, 16, 379-414.
2. Raetz, C. H. R.; Whitfield, C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 2002, 71, 635-700.
3. Schumann, R. R.; Leong, S. R.; Flaggs, G. W.; Gray, P. W.; Wright, S. D.; Mathison, J. C.; Tobias, P. S.; Ulevitch, R. J. Structure and function of lipopolysaccharide binding protein. Science 1990, 249, 1429-1431.
4. Miller, S. I.; Ernst, R. K.; Bader, M. W. LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 2005, 3, 36-46.
5. Pristovšek, P.; Kidrič, J. The search for molecular determinants of LPS inhibition by proteins and peptides. Curr. Top. Med. Chem. 2004, 4, 1185-1201.
6. Hoess, A.; Watson, S.; Silber, G. R.; Liddington, R. Crystal structure of an endotoxin-neutralizing protein from the horeshoe crab, Limulus anti-LPS factor, at 1.5 Å resolution EMBO J. 1993, 12, 3351-3356.
7. Battafarano, R. J.; Dahlberg, P. S.; Ratz, C. A.; Johnston, J. W.; Gray, B. H.; Haseman, J. R.; Mayo, K. H.; Dunn, D. L. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosos factor-alpha secretion in vitro. Surgery 1995, 118, 318-324.
8. Taylor, A. H.; Heavner, G.; Nedelman, M.; Sherris, D.; Brunt, E.; Knight, D.; Ghrayeb, J. Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS binding protein. J. Biol. Chem. 1995, 270, 17934-17938.
9. Reyes, O.; Vallespi, M. G.; Garay, H. E.; Cruz, L. J.; Gonzalez, L. J.; Chinea, G.; Buurman, W.; Arana, M. J. Identification of single amino acid residues essential for the binding of lipopolysaccharide (LPS) to LPS binding protein (LBP) residues 86-99 by using an Ala-scanning library. J. Pept. Sci. 2002, 8, 144-50.
10. Pristovšek, P.; Kidrič, J. Solution structure of polymyxins B and E and effect of binding to lipopoly-saccharide: an NMR and molecular modelling study. J. Med. Chem. 1999, 42, 4606-4613.
11. Japelj, B.; Pristovšek, P.; Majerle, A.; Jerala, R. Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide. J. Biol. Chem. 2005, 280, 16955-16961.
12. Pristovšek, P.; Feher, K.; Szilagyi, L.; Kidrič, J. Structure of a synthetic fragment of the LALF protein when bound to lipopolysaccharide. J. Med. Chem. 2005, 48, 1666-1670.
13. Clore, G. M.; Gronenborn, A. M. Theory and applications of the transferred nuclear Overhauser effect to the study of the conformations of small ligands bound to proteins. J. Magn. Reson. 1982, 48, 402-417.
14. Wüthrich, K. NMR of Proteins and Nucleic Acids; Wiley: New York, 1986.
15. Beamer, L. J.; Carroll, S. F.; Eisenberg, D. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 1997, 76, 1861-1864.
16. Hwang, P. M.; Zhou, N.; Shan, X.; Arrowsmith, C. H.; Vogel, H. J. Three-dimensional structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry 1998, 37, 4288-4298.
17. Post, C. B. Exchange-transferred NOE spectroscopy and bound ligand structure determination. Curr. Opin. Struct. Biol. 2003, 13, 581-588.
18. Yan, J.; Kline, A. D.; Mo, H.; Zartler, E. R.; Shapiro, M. J. Epitope mapping of ligand-receptor interactions by diffusion NMR. J. Am. Chem. Soc. 2002, 124, 9984-9985.
19. Zabell, A. P.; Post, C. B. Docking multiple conformations of a flexible ligand into a protein binding site using NMR restraints. Proteins 2002, 46, 295-307.
20. Glen, R. C.; Allen, S. C. Ligand-protein docking: cancer research at the interface between biology and chemistry. Curr. Med. Chem. 2003, 10, 763-767.
21. Verkhivker, G. M.; Bouzida, D.; Gehlhaar, D. K.; Rejto, P. A.; Freer, S. T.; Rose, P. W. Complexity and simplicity of ligand-macromolecule interactions: the energy landscape perspective. Curr. Opin. Struct. Biol. 2002, 12, 197-203.
22. Güntert, P.; Mumenthaler, C.; Wüthrich, K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 1997, 273, 283-298.
23. Dauber-Ogusthorpe, P.; Roberts, V. A.; Ogusthorpe, D. J.; Wolff, D. J.; Genest, M.; Hagler, A. T. Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase-trimethoprim, a drug-receptor system. Proteins: Struct., Funct., Genet. 1988, 4, 31-47.
24. Ferguson, A. D.; Hofmann, E.; Coulton, J. W.; Diederichs, K.; Welte, W. Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science 1998, 282, 2215-2220.
25. Morris, G. M.; Goodsell, D. S.; Halliday, R. S.; Huey, R.; Hart, W. E.; Belew, R. K.; Olson, A. J. Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J. Comput. Chem. 1998, 19, 1639-1662.
26. Simčič, S.; Wraber-Herzog, B.; Pristovšek, P.; Sollner Dolenc, M.; Gobec, S.; Urleb, U. In vitro trials for discovering novel immunomodulatory substanced and possibilities for immunointerventions. Med. Razgledi 2004, 43 (Suppl. 5), 15-19.